About Editas Medicine (EDIT)
Editas Medicine, Inc. is a genome editing company. It is engaged in treating patients with genetically defined diseases by correcting their disease-causing genes. It operates through developing and commercializing genome editing technology segment. I... Read more
- USD1.60
- USD1.61
- USD1.50
- USD6.69
- 15.80%
- 32M
- 1.08M
- 2.25M
- 107M
- 0.91
- -69.90%
Stock News
yesterday
Where Trump’s tariffs and economic promises stand as he nears 100 days in office
MarketWatch
yesterday
Why Universal Logistics (ULH) Stock Is Down Today
Yahoo
yesterday
38-year-old turned his New York apartment into a 'spice warehouse'—now his company brings in $8 million a year
CNBC
yesterday
We're putting a big weekly winner in the Bullpen but see more room for the stock to run
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
